Clinical Trial
Also known as: clinical study · human trial
A prospective research study testing a compound in human subjects under controlled protocol, typically organized into Phase 1 through Phase 4.
Clinical trials are the highest-tier evidence in compound research. Phase 1 tests safety and dosing in small healthy cohorts; Phase 2 tests efficacy in affected populations; Phase 3 tests at scale against existing treatments; Phase 4 is post-approval surveillance. Only a subset of research peptides have completed full clinical trial programs — many are pre-Phase 2 or non-US registrations.
In DoseCraft's three-lane evidence system, compounds with positive Phase 2+ clinical trial data earn 'Clinical' tier classification. The absence of clinical trials does not mean a compound is ineffective — it means rigorous human data isn't available, which is a meaningful context flag for any research protocol.
Related Terms
Preclinical Study
Research conducted in cell cultures (in vitro) or animal models (in vivo) prior to any human testing.
RCT (Randomized Controlled Trial)
A clinical trial design in which participants are randomly assigned to intervention or control groups, considered the gold-standard for causal inference.
Three-Lane Evidence System
DoseCraft's framework categorizing every compound across three independent evidence dimensions: Clinical, Expert, and Experimental.
Mechanistic Study
Research investigating the molecular and cellular pathways through which a compound produces its effects.
Look up any peptide term inside DoseCraft Pro
The glossary is just the start. Inside DoseCraft you get 90+ compound deep-dives, a PK-aware protocol engine, interaction checker, and vendor trust scores — every term surfaced in protocol-design context, not a separate page.
Start Free Trial